GABAB receptor antagonists:New tools and potential new drugs

Pharmacochemistry Library

Volumn 24, Issue C, 1996, Pages 253-270

  Froestl, W ^a   Mickel, S J ^a   Mondadori, C ^a   Olpe, H R ^a   Pozza, M F ^a   Waldmeier, P C ^a   Bittiger, H ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957202737     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(96)80021-3     Document Type: Article

References (86)

1. Hill D.R., and Bowery N.G. Nature 290 (1981) 149-152
2. Morishita R., Kato K., and Asano T. FEBS Lett 271 (1990) 231-235
3. Bowery N.G., Hill D.R., and Hudson A.L. Neuropharmacol 24 (1985) 207-210
4. Thompson S.M., and Gaehwiler B.H. J Physiol 451 (1992) 329-345
5. Gage P.W. Trends Neurosci 15 (1992) 46-51
6. Lesage F., Duprat F., Fink M., Guillemare E., Coppola T., Lazdunski M., and Hugnot J.-P. FEBS Lett 353 (1994) 37-42
7. Karschin C., Schreibmayer W., Dascal N., Lester H., Davidson N., and Karschin A. FEBS Lett 348 (1994) 139-144
8. Kobayashi T., Ikeda K., Ichikawa T., Abe S., Togashi S., and Kumanishi T. Biochem Biophys Res Commun 208 (1995) 1166-1173
9. Dutar P., and Nicoll R.A. Nature 332 (1988) 156-158
10. Davies C.H., Davies S.N., and Collingridge G.L. J Physiol 424 (1990) 513-531
11. Mintz I.M., and Bean B.P. Neuron 10 (1993) 889-898
12. Potier B., and Dutar P. Eur J Pharmacol 231 (1993) 427-433
13. Kerr D., Ong J., Prager R.H., Gynther B.D., and Curtis D.R. Brain Res 405 (1987) 150-154
14. Kerr D., and Ong J. Med Res Rev 12 (1992) 593-636
15. Kerr D., Ong J., Johnston G., Abbenante J., and Prager R.H. Neurosci Lett 107 (1989) 239-244
16. Kerr D., Ong J., Johnston G., Abbenante J., and Prager R.H. Neurosci Lett 92 (1988) 92-96
17. Curtis D.R., Gynther B.D., Beattie D.T., Kerr D., and Prager R.H. Neurosci Lett 92 (1988) 97-101
18. Dingwall J.G., Ehrenfreund J., Hall R.G., and Jack J. Phosphorus Sulfur 30 (1987) 571-574
19. Dingwall J.G., Ehrenfreund J., and Hall R.G. Tetrahedron 45 (1989) 3787-3808
20. Baylis E.K., Campbell C.D., and Dingwall J.G. J Chem Soc Perkin Trans I 2845-2853 (1984)
21. Howson W., Mistry J., Broekman M., and Hills J.M. Bioorg Med Chem Lett 3 (1993) 515-518
22. Froestl W., Mickel S.J., Hall R.G., von Sprecher G., Strub D., Baumann P.A., Brugger F., Gentsch C., Jaekel J., Olpe H.-R., Rihs G., Vassout A., Waldmeier P.C., and Bittiger H. J Med Chem 38 (1995) 3297-3312
23. Abstr 16.10. Bittiger H., Reymann N., Hall R., and Kane P. Eur J Neurosci Suppl (1988)
24. Hall R.G., Kane P.D., Bittiger H., and Froestl W. J Labelled Compd Radiopharm 36 (1995) 129-135
25. B Receptors in Mammalian Function (1990), Wiley, Chichester 47-60
26. Olpe H.-R., Karlsson G., Pozza M.F., Brugger F., Steinmann M., van Riezen H., Fagg G., Hall R.G., Froestl W., and Bittiger H. Eur J Pharmacol 187 (1990) 27-38
27. Froestl W., Mickel S.J., von Sprecher G., Diel P.J., Hall R.G., Maier L., Strub D., Melillo V., Baumann P.A., Bernasconi R., Gentsch C., Hauser K., Jaekel J., Karlsson G., Klebs K., Maître L., Marescaux C., Pozza M.F., Schmutz M., Steinmann M.W., van Riezen H., Vassout A., Mondadori C., Olpe H.-R., Waldmeier P.C., and Bittiger H. J Med Chem 38 (1995) 3313-3331
28. Olpe H.-R., Steinmann M.W., Ferrat T., Pozza M.F., Greiner K., Brugger F., Froestl W., Mickel S.J., and Bittiger H. Eur J Pharmacol 233 (1993) 179-186
29. Lingenhoehl K., and Olpe H.-R. Pharmacol Commun 3 (1993) 49-54
30. 288.10. Emmett M.R., Waldmeier P., and Caprioli R.M. Neurosci Abstr 19 (1993) 695
31. Mondadori C., Preiswerk G., and Jaekel J. Pharmacol Commun 2 (1992) 93-97
32. Mondadori C., Jaekel J., and Preiswerk G. Behav Neural Biol 60 (1993) 62-68
33. Bittiger H., Bernasconi R., Froestl W., Hall R., Jaekel J., Klebs K., Krueger L., Mickel S.J., Mondadori C., Olpe H.-R., Pfannkuch F., Pozza M., Probst A., van Riezen H., Schmutz M., Schuetz H., Steinmann M.W., Vassout A., Waldmeier P., Bieck P., Farger G., Gleiter C., Schmidt E.K., and Marescaux C. Pharmacol Commun 2 (1992) 70-74
34. Bittiger H., Froestl W., Mickel S.J., and Olpe H.-R. Trends Pharmacol Sci 14 (1993) 391-394
35. Suppl: 74P. Carletti R., Libri V., and Bowery N.G. Br J Pharmacol 109 (1993)
36. Suppl. Marescaux C., Vergnes M., and Bernasconi R. J Neural Transm 35 (1992) 179-188
37. Liu Z., Vergnes M., Depaulis A., and Marescaux C. Neurosci 48 (1992) 87-93
38. Marescaux C., Liu Z., Bernasconi R., and Vergnes M. Pharmacol Commun 2 (1992) 57-62
39. Hosford D.A., Clark S., Cao Z., Wilson W.A., Lin F., Morrisett R.A., and Huin A. Science 257 (1992) 398-401
40. Snead O.C. Pharmacol Commun 2 (1992) 63-69
41. Klebs K., Bittiger H., Froestl W., Glatt A., Hafner T., Mickel S., Olpe H.-R., and Schmutz M. Pharmacol Commun 2 (1992) 171-172
42. Crunelli V., and Leresche N. Trends Neurosci 14 (1991) 16-21
43. Porsolt R.D., Bertin A., Blavet N., Deniel M., and Jalfre M. Eur J Pharmacol 57 (1979) 201-210
44. Pratt G.D., and Bowery N.G. Br J Pharmacol 110 (1993) 724-735
45. Papp M. (personal communication).
46. Willner P., Towell A., Sampson D., Sophokleous S., and Muscat R. Psychopharmacol 93 (1987) 358-364
47. Bonanno G., and Raiteri M. Trends Pharmacol Sci 14 (1993) 259-261
48. Gemignani A., Paudice P., Bonanno G., and Raiteri M. Mol Pharmacol 46 (1994) 558-562
49. Mott D.D., and Lewis D.V. In: Bradley R.J., and Harris R.A. (Eds). International Review of Neurobiology (1994), Academic Press, San Diego 97-223
50. Bowery N.G. Ann Rev Pharmacol Toxicol 33 (1993) 109-147
51. Bowery N.G., and Pratt G.D. Arzneim Forsch/Drug Res 42 (1992) 215-223
52. Ong J., and Kerr D. Life Sci 46 (1990) 1489-1501
53. Bliss T.V.P., and Collingridge G.L. Nature 361 (1993) 31-39
54. Lacaille J.-C., and Williams S. Neurosci 36 (1990) 349-359
55. Hebb D.O. The Organization of Behavior: A Neuropsychological Theory (1949), Wiley, New York
56. Ghosh A., and Greenberg M.E. Science 268 (1995) 239-247
57. Olpe H.-R., and Karlsson G. Naunyn Schmiedeberg's Arch Pharmacol 342 (1990) 194-197
58. Olpe H.-R., Woerner W., and Ferrat T. Experientia 49 (1993) 542-546
59. Collingridge G.L., Randall A.D., Davies C.H., and Alford S. In: Sato R., Bock G.R., and Widdows K. (Eds). Interactions Among Cell Signalling Systems (Ciba Foundation Symposium 164) (1992), Wiley, Chichester 162-175
60. Davies C.H., Starkey S.J., Pozza M.F., and Collingridge G.L. Nature 349 (1991) 609-611
61. Davies C.H., and Collingridge G.L. J Physiol 472 (1993) 245-265
62. Mott D.D., and Lewis D.V. Science 252 (1991) 1718-1720
63. Mott D.D., and Lewis D.V. In: Ribak C.E., Gall C.M., and Mody I. (Eds). The Dentate Gyrus and Its Role in Seizures (Epilepsy Res. Suppl. 7) (1992), Elsevier, Amsterdam 119-134
64. Mott D.D., Xie C.-W., Wilson W.A., Swartzwelder H.S., and Lewis D.V. J. Neurophysiol. 69 (1993) 674-691
65. Pitler T.A., and Alger B.E. J Neurophysiol 72 (1994) 2317-2327
66. Olpe H.-R., Steinmann M.W., Greiner K., and Pozza M.F. Naunyn Schmiedeberg's Arch Pharmacol 349 (1994) 473-477
67. Wagner J.J., and Alger B.E. J Neurosci 15 (1995) 1577-1586
68. Linden D.J. Neuron 12 (1994) 457-472
69. Chu D.C.M., Penney J.B., and Young A.B. Neurosci Lett 82 (1987) 246-252
70. Chu D.C.M., Penney J.B., and Young A.B. Neurology 37 (1987) 1454-1459
71. Froestl W., Mickel S.J., von Sprecher G., Bittiger H., and Olpe H.-R. Pharmacol Commun 2 (1992) 52-56
72. Froestl W., Furet P., Hall R.G., Mickel S.J., Strub D., von Sprecher G., Baumann P.A., Bernasconi R., Brugger F., Felner A., Gentsch C., Hauser K., Jaekel J., Karlsson G., Klebs K., Maître L., Marescaux C., Moser P., Pozza M.F., Rihs G., Schmutz M., Steinmann M.W., van Riezen H., Vassout A., Mondadori C., Olpe H.-R., Waldmeier P.C., and Bittiger H. In: Testa B., Kyburz E., Fuhrer W., and Giger R. (Eds). Perspectives in Medicinal Chemistry (1993), Verlag Helvetica Chimica Acta, Basel 259-272
73. Froestl W., Mickel S.J., and Bittiger H. Curr Opin Ther Pat 3 (1993) 561-567
74. Bittiger H., Froestl W., Mickel S.J., and Olpe H.-R. Trends Pharmacol Sci 14 (1993) 391-393
75. Froestl W, Mickel SJ. In: Enna S, Bowery NG, eds. The GABA Receptors. 2nd ed. Totowa, N. J.: Humana Press, (in press).
76. Topliss J.G. J Med Chem 15 (1972) 1006-1011
77. Bittiger H., Reymann N., Froestl W., and Mickel S.J. Pharmacol Commun 2 (1992) 23
78. Lanza M., Fassio A., Gemignani A., Bonanno G., and Raiteri M. Eur J Pharmacol 237 (1993) 191-195
79. Brugger F., Wicki U., Olpe H.-R., Froestl W., and Mickel S. Eur J Pharmacol 235 (1993) 153-155
80. Lacey G., and Curtis D.R. Exp Brain Res 101 (1994) 59-72
81. Turgeon S.M., and Albin R.L. Neurosci 62 (1994) 59-72
82. Davies C.H., Pozza M.F., and Collingridge G.L. Neuropharmacol 32 (1993) 1071-1073
83. Blake J.F., Cao C.Q., Headley P.M., Collingridge G.L., Brugger F., and Evans R.H. Neuropharmacol 32 (1993) 1437-1440
84. Jarolimek W., Demmelhuber J., Bijak M., and Misgeld U. Neurosci Lett 154 (1993) 31-34
85. Lambert N.A., and Wilson W.A. Neuron 11 (1993) 1057-1067
86. Waldmeier P.C., Wicki P., Feldtrauer J.-J., Mickel S.J., Bittiger H., and Baumann P.A. Br J Pharmacol 113 (1994) 1515-1521